INSULIN DEGLUDEC (Tresiba®)

Clinical Indication

Diabetes mellitus in adults

Comments

Conditional on prescriber being trained to select appropriate patients
MUST BE PRESCRIBED BY BRAND NAME

Tresiba (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filled pens have been out of stock since 31^st July 2023 and have subsequently been discontinued. Prescribers should not initiate patients on Tresiba FlexTouch 100units/ml pre-filled pens and should instead consider Tresiba Penfill cartridges where reusable pens are available as sufficient cartridges to support increased demand. In the community, reusable pens are normally issued at same time as initial cartridge prescription.  UHL continue to have no supplies of the reusable pens so will need to follow the SBAR with respect to changing to higher strength flextouch for Tresiba.

In UHL where access to reusable pens is limited following SBAR should be followed Tresiba® Flextouch SBAR

Date of classification

June 2015